Erlotinib and nausea Patient Reports February 11, 2012

Erlotinib Side Effects Report #5976474-1
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 14, 2008. Male patient, 78 years of age, weighting 189.6 lb, was diagnosed with renal cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood potassium decreased, blood urea increased, nausea , pneumonia , protein total decreased, rash , scleral hyperaemia, ventricular tachycardia. Erlotinib dosage: (125 MG,QD), ORAL. During the same period patient was treated with ASPIRIN, LIPITOR, LASIX, POTASSIUM CHLORIDE, PLAVIX, TOPROL, FOLIC ACID. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5224439-X
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 12, 2007. Male patient, 88 years of age, was diagnosed with prostate cancer  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood calcium decreased, blood creatine increased, blood glucose increased, cardiac failure congestive, haemoglobin decreased, lung infiltration, nausea , pleural effusion, pulmonary oedema. Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with SYNTHROID, HUMULIN, FUROSEMIDE, COREG, LISINOPRIL, FERROUS SULPHATE, LEUPROLIDE ACETATE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5803938-3
Erlotinib side effect was reported by a Physician from SPAIN on June 18, 2008. Female patient, 76 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, gastrointestinal toxicity, malignant neoplasm progression, nausea , pancreatic carcinoma. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE, LOPERAMIDA, EPOETIN BETA, NEUPOGEN, BUPRENORFINE HYDROCHLORIDE, METAMIZOL MAGNESIUM, FENTANILO, ENOXAPARIN. Patient was hospitalized. Patient died on 02/09/2008.

Erlotinib Side Effects Report #5380022-7
Erlotinib side effect was reported by a Physician from PERU on June 18, 2007. Female patient, 54 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, aspartate aminotransferase increased, blood glucose increased, dehydration, diarrhoea, nausea , prothrombin time prolonged, pyrexia. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, GLYBURIDE, METFORMIN, ALPRAZOLAM, ACETAMINOPHEN, OMEPRAZOLE, TRAMADOL. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5648131-2
Erlotinib side effect was reported by a Physician from GERMANY on Feb 15, 2008. Male patient, 63 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain , cardiac failure, nausea . Erlotinib dosage: unknown. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6053251-7
Erlotinib side effect was reported by a Physician from FRANCE on Jan 07, 2009. Female patient, 62 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain , anorexia, dysphonia, escherichia sepsis, malignant neoplasm progression, nausea , vocal cord paralysis. Erlotinib dosage: unknown. During the same period patient was treated with GEMCITABINE, IMOVANE, PROPRANOLOL, DURAGESIC, ACTISKENAN, PRIMPERAN, ZOFRAN, FORTIMEL. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5916941-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 24, 2008. Female patient, 74 years of age, weighting 149.7 lb, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, intra-abdominal haemorrhage, nausea , platelet count increased, prothrombin time prolonged. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, COUMADIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5259452-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 20, 2007. Female patient, 57 years of age, weighting 160.0 lb, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: hypertension, nausea . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, ARANESP, ATIVAN, ANZEMET. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5300467-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 26, 2007. Female patient, 57 years of age, weighting 160.0 lb, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, hypertension, nausea . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, ARANESP, ATIVAN, ANZEMET. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5829432-1
Erlotinib side effect was reported by a Physician from UNITED STATES on July 15, 2008. Female patient, 55 years of age, weighting 145.5 lb, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain , aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, haemoglobin decreased, hyponatraemia, nausea , platelet count decreased, pyrexia. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with IRINOTECAN, AMLODIPINE, DOXAZOSIN, LISINOPRIL, METOPROLOL TARTRATE, OXYCONTIN, PROTONIX. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5350994-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 22, 2007. Female patient, weighting 134.0 lb, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haemorrhage intracranial, metastases to central nervous system, nausea . Erlotinib dosage: 150 MG, ORAL. During the same period patient was treated with BEVACIZUMAB, LOVENOX. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4740923-7
Erlotinib side effect was reported by a Physician from UNITED STATES on July 19, 2005. Female patient, 57 years of age, weighting 179.9 lb, was diagnosed with oligodendroglioma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, myocardial infarction, nausea . Erlotinib dosage: unknown. During the same period patient was treated with TEMSIROLIMUS. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6140496-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 17, 2009. Female patient, 65 years of age, weighting 138.9 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, dehydration, dysphagia, mucosal inflammation, nausea , white blood cell count decreased. Erlotinib dosage: (100 MG,QD),ORAL. During the same period patient was treated with BEVACIZUMAB, TAXOL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5775135-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 28, 2008. Male patient, 64 years of age, weighting 138.9 lb, was diagnosed with oesophageal carcinoma, multiple myeloma  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: choking , dehydration, diarrhoea, epistaxis, nausea , oesophagitis, oral pain, weight decreased. Erlotinib dosage: (100 MG,QD) ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5797454-5
Erlotinib side effect was reported by a Physician from UNITED STATES on June 12, 2008. Male patient, 64 years of age, weighting 138.9 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: choking , dehydration, diarrhoea, epistaxis, nausea , odynophagia, oesophagitis, oral pain. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5783016-2
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2008. Male patient, weighting 138.9 lb, was diagnosed with oesophageal adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, disease progression, dysphagia, fatigue, nausea , odynophagia, oral intake reduced, weight decreased. Erlotinib dosage: 150 MG, QD, PO. During the same period patient was treated with BEVACIZUMAB, PROGRAF, MYFORTIC, PREVACID, LIPITOR, PREDNISONE, METOPROLOL SUCCINATE, ASPIRIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5822414-5
Erlotinib side effect was reported by a Physician from AUSTRALIA on July 07, 2008. Male patient, 85 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, dehydration, nausea , weight decreased. Erlotinib dosage: 100 MG QD ORAL. During the same period patient was treated with GEMCITABINE, ASPIRIN, METOCLOPRAMIDE, LOPERAMIDE, RANITIDINE. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5483736-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 09, 2007. Female patient, 78 years of age, weighting 184.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: decreased appetite, dehydration, malaise, nausea , pyrexia. Erlotinib dosage: 150 MG DAILY 047. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5518470-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 13, 2007. Female patient, 78 years of age, weighting 184.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, diarrhoea, headache , nausea . Erlotinib dosage: 150 MG DAILY 047. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5638851-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 22, 2008. Female patient, 78 years of age, weighting 184.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, diarrhoea, headache , nausea . Erlotinib dosage: 150 MG DAILY 047. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5670074-9
Erlotinib side effect was reported by a Physician from GERMANY on Feb 26, 2008. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: constipation , dehydration, fall , infection , malignant neoplasm progression, nausea . Erlotinib dosage: 150 MG (150 MG, QD), ORAL. During the same period patient was treated with OXYCODONE, MOVICOL, NEXIUM, NOVALGIN, INSULIN, METOCLOPRAMID, SPIRONOLACTONE. Patient was hospitalized. Patient died on 01/20/2007.

Erlotinib Side Effects Report #5946023-2
Erlotinib side effect was reported by a Physician from ISRAEL on Oct 22, 2008. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cough, dyspnoea, nausea , pleural effusion, respiratory failure, sepsis . Erlotinib dosage: 150 MG (150 MG, QD), ORAL. During the same period patient was treated with NORMITEN, GASTRO, ASPIRIN. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5836131-9
Erlotinib side effect was reported by a Consumer or non-health professional from on July 22, 2008. Male patient, 70 years of age, weighting 277.8 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, candidiasis, diarrhoea, nausea , neutrophil count decreased, sleep disorder . Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with PEMETREXED, FOLIC ACID, VITAMIN B12, DEXAMETHASONE, FUROSEMIDE, METOPROLOL TARTRATE, SPIRIVA, VIANI. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6063627-X
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 14, 2009. Male patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activities of daily living impaired, aphonia, cough, diarrhoea, diplopia, disease progression, nausea , optic ischaemic neuropathy, rash . Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PEMETREXED, DEXAMETHASONE, COMPAZINE, FOLIC ACID. Patient recovered.


Erlotinib Side Effects Report #5844734-0
Erlotinib side effect was reported by a Physician from POLAND on July 29, 2008. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bradykinesia, depressed level of consciousness, headache , nausea , neurotoxicity, peripheral sensory neuropathy. Erlotinib dosage: 150 MG QD ORAL. During the same period patient was treated with METOCLOPRAMIDE, OMEPRAZOLE. Patient was hospitalized and became disabled. Patient recovered.

Erlotinib Side Effects Report #5862115-0
Erlotinib side effect was reported by a Health Professional from POLAND on Aug 11, 2008. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: balance disorder, bradykinesia, bradyphrenia, headache , hypertension, nausea , paraneoplastic syndrome, peripheral sensory neuropathy, somnolence. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with METOCLOPRAMIDE, OMEPRAZOLE. Patient was hospitalized and became disabled. Patient recovered.

Erlotinib Side Effects Report #6060234-X
Erlotinib side effect was reported by a Health Professional from BELGIUM on Jan 16, 2009. Female patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, dizziness , nausea , oral fungal infection, renal failure acute, weight decreased. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with REPAGLINIDE, NEBIVOLOL, TIOTROPIUM, ENOXAPARIN, SERETIDE, ALLOPURINOL, SIMVASTATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5007686-1
Erlotinib side effect was reported by a Physician from NETHERLANDS on Apr 19, 2006. Female patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: mallory-weiss syndrome, nausea . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with ACENOCOUMAROL, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5237023-9
Erlotinib side effect was reported by a Physician from SWEDEN on Jan 26, 2007. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, diarrhoea, haemoptysis, lung neoplasm malignant, malignant neoplasm progression, malnutrition, nausea , performance status decreased. Erlotinib dosage: 150 MG, ORAL. During the same period patient was treated with OXYCONTIN, PREDNISOLONE, ACETAMINOPHEN, COZAAR, METOPROLOL TARTRATE, KLEXANE, IMOVANE, OXYCODONE. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5362706-X
Erlotinib side effect was reported by a Physician from SWEDEN on May 29, 2007. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, lung neoplasm malignant, malignant neoplasm progression, malnutrition, nausea , pain , performance status decreased. Erlotinib dosage: 150 MG, ORAL. During the same period patient was treated with OXYCONTIN, PREDNISOLONE, ACETAMINOPHEN, COZAAR, METOPROLOL TARTRATE, ENOXAPARIN, IMOVANE, OXYCODONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5526191-7
Erlotinib side effect was reported by a Physician from SWEDEN on Nov 06, 2007. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, lung neoplasm malignant, malignant neoplasm progression, malnutrition, metastases to bone, nausea , pain . Erlotinib dosage: 150 MG (150 MG,QD), ORAL. During the same period patient was treated with OXYCONTIN, PREDNISONE, ACETAMINOPHEN, COZAAR, METOPROLOL TARTRATE, ENOXAPARIN, IMOVANE, OXYCODONE. Patient was hospitalized. Patient died on 01/18/2007.

Erlotinib Side Effects Report #5259639-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 20, 2007. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, dizziness , dyspnoea exertional, gait disturbance, movement disorder , nausea , oesophageal pain. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6060255-7
Erlotinib side effect was reported by a Physician from POLAND on Jan 15, 2009. Female patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: fatigue, hypomagnesaemia, lung neoplasm malignant, malignant neoplasm progression, nausea . Erlotinib dosage: unknown. During the same period patient was treated with AMARYL, MAGNESIUM, TRAMADOL, KETOPROFEN, OMEPRAZOLE, TORECAN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5643861-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 12, 2008. Female patient, 47 years of age, weighting 183.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, effusion, lung consolidation, nausea , pneumonia . Erlotinib dosage: (150 MG, QD), ORAL. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5813696-4
Erlotinib side effect was reported by a Physician from UNITED STATES on July 16, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, metabolic acidosis, nausea . Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5875062-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Sept 08, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium difficile toxin test positive, dehydration, diarrhoea, haemoglobin decreased, nausea , pyrexia. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5885500-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Sept 15, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium difficile toxin test positive, dehydration, diarrhoea, haemoglobin decreased, nausea , pyrexia. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5910478-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 06, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, clostridium difficile colitis, dehydration, diarrhoea, nausea , pyrexia. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5920061-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 30, 2008. Male patient, 47 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood potassium decreased, blood sodium decreased, clostridium difficile colitis, dehydration, haemoglobin decreased, ileus, nausea , pyrexia, small intestinal obstruction. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5944242-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 20, 2008. Male patient, 47 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium difficile colitis, dehydration, diarrhoea, haemoglobin decreased, nausea , pseudomembranous colitis, pyrexia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6073105-X
Erlotinib side effect was reported by a Health Professional from CANADA on Feb 02, 2009. Female patient, 45 years of age, weighting 135.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, hypocalcaemia, hypomagnesaemia, nausea . Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with HUMULIN N, HUMULIN R, PERINDOPRIL ERBUMINE, CETIRIZINE, CRESTOR, ASPIRIN, PAROXETINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6088067-9
Erlotinib side effect was reported by a Health Professional from CANADA on Feb 06, 2009. Female patient, 45 years of age, weighting 135.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, hypocalcaemia, hypomagnesaemia, malaise, nausea . Erlotinib dosage: (150 MG, QD) ,ORAL; (100 MG, QD) ,ORAL. During the same period patient was treated with HUMULIN M, HUMULIN R, PERINDOPRIL ERBUMINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5494757-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 23, 2007. Female patient, weighting 180.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, diarrhoea, headache , nausea . Erlotinib dosage: 150 MG DAILY 047. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6050202-6
Erlotinib side effect was reported by a Physician from CANADA on Jan 06, 2009. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anxiety , dehydration, hypophagia, nausea , pain . Erlotinib dosage: unknown. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6092896-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 20, 2009. Male patient, weighting 127.5 lb, was diagnosed with nasopharyngeal cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: constipation , dehydration, nausea , pyrexia. Erlotinib dosage: 100 MG, QD. During the same period patient was treated with BEVACIZUMAB, CISPLATIN, ONDANSETRON, ACETAMINOFEN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5567677-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 30, 2007. Male patient, 80 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, asthenia, fatigue, nausea . Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5921249-2
Erlotinib side effect was reported by a Physician from CHILE on Sept 30, 2008. Female patient, 66 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, diplopia, hypertension, metastases to central nervous system, nausea . Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with EUTIROX, ENALAPRIL MALEATE, ALPRAZOLAM, CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5979480-6
Erlotinib side effect was reported by a Physician from CHILE on Nov 14, 2008. Female patient, 66 years of age, weighting 130.1 lb, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: condition aggravated, dehydration, diarrhoea, diplopia, hypertension, malignant neoplasm progression, metastases to central nervous system, nausea . Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with EUTIROX, ENALAPRIL MALEATE, ALIPRAZOLAM, CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient died on 09/23/2008.

Erlotinib Side Effects Report #4608558-4
Erlotinib side effect was reported by a Pharmacist from on Mar 11, 2005. Female patient was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: nausea , tremor. Erlotinib dosage: 150 MG DAILY ORAL. Patient recovered.


Erlotinib Side Effects Report #6099808-9
Erlotinib side effect was reported by a Physician from JAPAN on Feb 13, 2009. Female patient, 75 years of age, weighting 143.3 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, arterial thrombosis limb, diarrhoea, disease progression, nausea , rash . Erlotinib dosage: (150 MG, QD), ORAL; (150 MG, QD), ORAL. During the same period patient was treated with VITAMEDIN, METHYCOBAL, PRAVASTATIN, LOXONIN, SELBEX, NAUZELIN. Patient recovered.

Erlotinib Side Effects Report #5740034-8
Erlotinib side effect was reported by a Health Professional from JAPAN on Apr 29, 2008. Female patient, 60 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, dysgeusia, dyspepsia, nausea , reflux oesophagitis. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with DEPAS, DECADRON, CLONAZEPAM, MAGNESIUM OXIDE, LAXOBERON, HYALEIN, BICARBONATE IN PLASTIC CONTAINER. Patient recovered.

Erlotinib Side Effects Report #5988405-9
Erlotinib side effect was reported by a Health Professional from JAPAN on Nov 19, 2008. Female patient, 60 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, dysgeusia, dyspepsia, nausea , reflux oesophagitis. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with DEPAS, DECADRON, CLONAZEPAM, MAGNESIUM OXIDE, LAXOBERON, HYALEIN, BICARBONATE IN PLASTIC CONTAINER. Patient recovered.

Erlotinib Side Effects Report #5744845-4
Erlotinib side effect was reported by a Physician from UNITED STATES on May 01, 2008. Female patient, 55 years of age, weighting 153.0 lb, was diagnosed with head and neck cancer  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood chloride decreased, cellulitis , hypomagnesaemia, nausea , pain . Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with CISPLATIN, SYMBAX, AMBIEN, ATIVAN, ROXICET, GLUCOVANCE, DILAUDID, FENTANYL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5764153-5
Erlotinib side effect was reported by a Physician from UNITED STATES on May 20, 2008. Female patient, 55 years of age, weighting 153.0 lb, was diagnosed with head and neck cancer  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, cellulitis , feeding disorder, food intolerance, hypomagnesaemia, nausea , oral pain. Erlotinib dosage: (150 MG, QD) ORAL. During the same period patient was treated with CISPLATIN, SYMBAX, AMBIEN, ATIVAN, ROXICET, GLUCOVANCE, DILAUDID, FENTANYL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5737893-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 08, 2008. Female patient, 48 years of age, weighting 127.9 lb, was diagnosed with head and neck cancer  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: convulsion, hypertension, leukoencephalopathy, nausea . Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, CISPLATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5751366-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 20, 2008. Female patient, 48 years of age, weighting 127.9 lb, was diagnosed with head and neck cancer  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: convulsion, hypertension, leukoencephalopathy, nausea . Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, CISPLATIN, DEXAMETHASONE, VYTORIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6125199-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 03, 2009. Male patient, 65 years of age, weighting 187.4 lb, was diagnosed with glioblastoma multiforme and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, hydrocephalus , hypertension, nausea , neoplasm progression, treatment noncompliance. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, TEMODAR, LIPITOR, RINITIDINE, COLACE, LEVOTHYROXINE, ATIVAN, IMODIUM. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5916943-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 26, 2008. Female patient, weighting 120.8 lb, was diagnosed with glioblastoma multiforme and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cerebral disorder, convulsion, headache , intracranial tumour haemorrhage, muscle twitching, nausea . Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with SORAFENIB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5963873-7
Erlotinib side effect was reported by a Physician from DENMARK on Nov 05, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: aphasia , blood sodium decreased, headache , hypertension, ill-defined disorder, nausea , thyroid disorder. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5305173-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 30, 2007. Female patient, 62 years of age, weighting 259.0 lb, was diagnosed with colorectal cancer  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, bacterial infection , blood culture positive, dehydration, febrile neutropenia, hypertension, nausea . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, ARANESP, LOMOTIL, ZOMETA, CIPRO. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5351038-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 21, 2007. Female patient, 62 years of age, weighting 259.0 lb, was diagnosed with colorectal cancer  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, bacterial infection , blood culture positive, chest pain , dehydration, febrile neutropenia, hypertension, nausea . Erlotinib dosage: 150 MG (QD); ORAL. During the same period patient was treated with TOPOTECAN, ARANESP, LOMOTIL, ZOMETA, CIPRO. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5231284-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 19, 2007. Male patient, 64 years of age, weighting 162.0 lb, was diagnosed with colon cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, nausea . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, PHENERGAN, PERCOCET, PAXIL, ARANESP. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5307862-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 06, 2007. Male patient, 64 years of age, weighting 162.0 lb, was diagnosed with colon cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood potassium decreased, nausea . Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with TOPOTECAN, PHENERGAN, PERCOCET, PAXIL, ARANESP. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5529685-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 12, 2007. Female patient, 44 years of age, was diagnosed with colon cancer metastatic, breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, constipation , dehydration, haemoglobin decreased, lethargy, nausea , platelet count decreased, pneumonia . Erlotinib dosage: 75 MG, QD, ORAL. During the same period patient was treated with VINFLUNINE, FENTANYL PATCH, OXYCODONE, KYTRIL, PROMETHAZINE, LEVSIN, MORPHINE, DIAZEPAM. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4743431-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Aug 10, 2005. Male patient, weighting 180.8 lb, was diagnosed with colon cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cellulitis , deep vein thrombosis , dehydration, diarrhoea, failure to thrive, international normalised ratio increased, nausea , orthostatic hypotension, thrombophlebitis. Erlotinib dosage: 100MG QD ORAL. During the same period patient was treated with FLUOROURACIL, OXALIPLATIN, BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5194441-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 06, 2006. Male patient, 45 years of age, weighting 175.5 lb, was diagnosed with colon cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain , asthenia, diarrhoea, fatigue, haemoglobin decreased, nausea , neutrophil count decreased, oedema, ureteric obstruction. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with ATENOLOL, ATIVAN, DECADRON, EMEND, INSULIN, LISINOPRIL, LOVENOX. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5027676-2
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on June 14, 2006. Female patient, weighting 200.6 lb, was diagnosed with colon cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain , abdominal pain upper, chest pain , diarrhoea, fatigue, mucosal exfoliation, nausea , neutropenia, pyrexia. Erlotinib dosage: 100 MG DAILY ORAL. During the same period patient was treated with FLUOROURACIL, OXALIPITIN, AVASTIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5351034-4
Erlotinib side effect was reported by a Physician from UNITED STATES on May 23, 2007. Female patient, 56 years of age, was diagnosed with breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, gallbladder disorder, nausea , neutropenia, platelet count decreased, white blood cell count decreased. Erlotinib dosage: 75 MG (QD); ORAL. During the same period patient was treated with VINFLUNINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5351040-X
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on May 21, 2007. Female patient, 56 years of age, weighting 150.4 lb, was diagnosed with breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: gallbladder disorder, nausea , neutropenia, platelet count decreased, tremor. Erlotinib dosage: 75 MG (QD); ORAL. During the same period patient was treated with VINFLUNINE. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #6015310-4
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 05, 2008. Male patient, weighting 135.6 lb, was diagnosed with bile duct cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain , abdominal pain upper, constipation , feeling abnormal, haematemesis, hypertension, nausea , neck pain, pneumomediastinum. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, LISINOPRIL, OXYCONTIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4744883-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on June 10, 2005. Male patient, 80 years of age, weighting 164.0 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium colitis, fatigue, haematocrit normal, nausea , occult blood positive, orthostatic intolerance, weight decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GLEEVEC, LOVENOX, PHENOL, SIMETHICONE, QUININE SULPHATE, MORPHINE, PROMETHAZINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4599678-1
Erlotinib side effect was reported by a Health Professional from on Mar 04, 2005. Female patient, 73 years of age, weighting 133.8 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: acute prerenal failure, blood pressure decreased, dehydration, diarrhoea, feeling abnormal, nausea . Erlotinib dosage: 150 MG QD PO. During the same period patient was treated with ATENOLOL, COLCHICINE, FOLIC ACID, LIPITOR, ZESTORETIC, XANAX, OXYCODONE. Patient recovered.

Erlotinib Side Effects Report #5284210-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 30, 2007. Female patient, 72 years of age, weighting 151.5 lb, was diagnosed with salivary gland cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, blood sodium decreased, eye infection , fatigue, nausea , oral discomfort, staphylococcal infection . Erlotinib dosage: 75 MG PO QD. During the same period patient was treated with VINFLUNINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5088393-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on July 10, 2006. Male patient, 66 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, dehydration, diarrhoea, hypercalcaemia, nausea , urinary tract infection , weight decreased. Erlotinib dosage: 150 MG (QD),ORAL. During the same period patient was treated with CETUXIMAB, ASPIRIN, NAPROXEN, LEVAQUIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5394594-X
Erlotinib side effect was reported by a Physician from UNITED STATES on July 06, 2007. Female patient, 44 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, diarrhoea, gingival bleeding, hypokalaemia, hyponatraemia, nausea , pancytopenia, pyrexia. Erlotinib dosage: 75 MG (QD), ORAL. During the same period patient was treated with PEGINTERFERON ALFA, SUTENT, CELEXA, VERAPAMIL, NORTRIPTYLINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5413168-5
Erlotinib side effect was reported by a Physician from UNITED STATES on July 24, 2007. Female patient, 44 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, diarrhoea, gingival bleeding, hypokalaemia, hyponatraemia, liver function test abnormal, nausea , pancytopenia. Erlotinib dosage: 75 MG (QD), ORAL. During the same period patient was treated with PEGINTERFERON ALFA, SUTENT, CELEXA, VERAPAMIL, NORTRIPTYLINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5932680-3
Erlotinib side effect was reported by a Physician from JAPAN on Oct 09, 2008. Male patient, 26 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, nausea , pyrexia, rash . Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with OXYCONTIN, NOVAMIN, MORPHINE, MAGMITT, PURSENNID, LOXONIN, MUCOSTA. Patient was hospitalized. Patient recovered.